Nerve block showdown: which works best for pain after obesity surgery?
NCT ID NCT06841783
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two ultrasound-guided nerve block techniques—erector spinae plane block and modified thoracoabdominal nerve block—for pain control in 40 obese patients undergoing laparoscopic sleeve gastrectomy. The goal was to see which method delays the need for rescue pain medication and reduces overall opioid use. Both techniques aim to provide effective pain relief while minimizing opioid-related risks like nausea and breathing problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nerve block (ultrasound-guided erector spinae plane block or modified thoracoabdominal nerve block)
- What this could lead to
- If one technique proves better, it could offer a safer, opioid-sparing pain management option for obese patients after weight-loss surgery.
- What could go wrong
- This is a small, completed trial with only 40 participants, so results may not apply to all patients. Both techniques are well-established, so no major breakthrough is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. ASA II \& ASA III. 2. Gender both males and females 3. Age group: from 18 to 65 years old Exclusion Criteria: * • Patient refusal. * Uncooperative patients. * Allergy to local anesthetics. * Anatomical abnormality at injection site. * Redo or combined cholecystectomy surgery. * Infection at injection site.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kasr Alainy
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?